Skip to search formSkip to main contentSkip to account menu

KB 944

Known as: KB-944 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
KB-944 (10(-5)-10(-4) M) decreased the action potential duration measured at 30% repolarization and hyperpolarized the resting… 
1983
1983
Summary We compared the cardiac and coronary vasodilator actions of a new calcium-antagonistic vasodilator, KB-944, in isolated… 
1982
1982
A comparative study was made between the cardiac action of diethyl 4-(benzothiazol-2-yl)benzylphosphonate (KB-944) and those of… 
1982
1982
Vasodilator action of diethyl 4-(benzothiazol-2-yl)benzylphosphonate (KB-944) was mainly examined in comparison with papaverine… 
1982
1982
Hypotensive effect of KB-944 was examined in comparison with diltiazem and nifedipine in normotensive rats, spontaneously… 
1982
1982
The vasodilator mechanism of diethyl 4-(benzothiazol-2-yl)benzylphosphonate (KB-944) was investigated in anesthetized dogs and… 
1982
1982
Using male and female Beagles, we studied the subacute toxicity of diethyl 4-(benzothiazol-2-yl)benzylphosphonate (KB-944… 
1982
1982
Effects of diethyl 4-(benzothiazol-2-yl)benzylphosphonate (KB-944), a new chemical class of Ca-antagonist, on three types of… 
1982
1982
The acute toxicity of diethyl 4-(benzothiazol-2-yl)benzylphosphonate (KB-944) was studied in mice, rats and dogs: In mice and… 
1982
1982
Diethyl 4-(benzothiazol-2-yl)benzylphosphonate (KB-944), a new Ca-antagonist, in the dose range of 25--200 mg/kg/day, was orally…